The Oswestry Spinal Risk Index (OSRI) in assessing prognosis of patients with spinal metastases.
Brain Spine
2022
2
Global comparison of awake and asleep mapping procedures in glioma surgery: An international multicenter survey.
Neuro-Oncol Pract
2022
9
2
123-132
Primary Bone Tumors of the Spine-Proposal for Treatment Based on a Single Centre Experience.
Diagnostics (Basel)
2022
12
9
Postoperative communicating hydrocephalus following glioblastoma resection: Incidence, timing and risk factors.
Front Oncol
2022
12
Incidence of discoligamentous injuries in patients with acute central cord syndrome and underlying degenerative cervical spinal stenosis.
Brain Spine
2022
2
Anterior Pituitary Hormones in Blood and Cerebrospinal Fluid of Patients in Neurocritical Care.
touchREV Endocrinol
2022
18
1
71-79
Subcortical motor ischemia can be detected by intraoperative MRI within 1 h - A feasibility study.
Brain Spine
2022
2
Digital cognitive testing using a tablet-based app in patients with brain tumors: a single-center feasibility study comparing the app to the gold standard.
Neurosurg Focus
2022
52
6
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort.
Neuro-oncol
2022
24
10
1726-1735
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.
Neurol Res Pract
2022
4
1